Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
FI943513A0 - Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja - Google Patents
[go: Go Back, main page]

FI943513A0 - Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja - Google Patents

Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja

Info

Publication number
FI943513A0
FI943513A0 FI943513A FI943513A FI943513A0 FI 943513 A0 FI943513 A0 FI 943513A0 FI 943513 A FI943513 A FI 943513A FI 943513 A FI943513 A FI 943513A FI 943513 A0 FI943513 A0 FI 943513A0
Authority
FI
Finland
Prior art keywords
ones
phenylureidoazepin
benzazepin
useful
cholecystokinin antagonists
Prior art date
Application number
FI943513A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943513A7 (fi
FI943513L (fi
Inventor
Iii John A Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943513A7 publication Critical patent/FI943513A7/fi
Publication of FI943513L publication Critical patent/FI943513L/fi
Publication of FI943513A0 publication Critical patent/FI943513A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI943513A 1992-01-27 1992-12-16 Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja FI943513A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27
PCT/US1992/010720 WO1993015059A1 (en) 1992-01-27 1992-12-16 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists

Publications (3)

Publication Number Publication Date
FI943513A7 FI943513A7 (fi) 1994-07-26
FI943513L FI943513L (fi) 1994-07-26
FI943513A0 true FI943513A0 (fi) 1994-07-26

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943513A FI943513A0 (fi) 1992-01-27 1992-12-16 Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja

Country Status (19)

Country Link
EP (1) EP0625145A1 (sr)
JP (1) JPH07503465A (sr)
KR (1) KR950700257A (sr)
CN (1) CN1074903A (sr)
AU (1) AU3276193A (sr)
BR (1) BR9207071A (sr)
CA (1) CA2117367A1 (sr)
CZ (1) CZ391092A3 (sr)
FI (1) FI943513A0 (sr)
HU (1) HUT70496A (sr)
IL (1) IL104472A0 (sr)
MX (1) MX9300409A (sr)
NO (1) NO942775L (sr)
NZ (1) NZ245759A (sr)
RU (1) RU94038063A (sr)
TW (1) TW213901B (sr)
WO (1) WO1993015059A1 (sr)
YU (1) YU4393A (sr)
ZA (1) ZA93582B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (es) * 1993-07-14 1997-04-01 Pfizer Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
JP2862675B2 (ja) * 1993-07-26 1999-03-03 フアイザー・インコーポレイテツド 選択的コレシストキニン−b受容体拮抗薬としてのテトラヒドロ−1h−ベンゾアゼピノンおよびヘキサヒドロアゼピノン
CA2176019A1 (en) * 1993-11-22 1995-06-01 John J. Baldwin 3-acylaminobenzazepines
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
WO1996010564A1 (en) * 1994-10-04 1996-04-11 Pfizer Inc. Processes and intermediates for preparing 3-amino-benzo(b)azepinones
ES2171196T3 (es) * 1994-10-14 2002-09-01 Glaxosmithkline Spa Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
DE10153348A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte Benzo(b)azepin-2-on-Verbindungen
WO2007120160A2 (en) * 2005-06-16 2007-10-25 Novartis Ag Lactam containing hcv inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
CN1074903A (zh) 1993-08-04
NZ245759A (en) 1997-06-24
WO1993015059A1 (en) 1993-08-05
JPH07503465A (ja) 1995-04-13
CZ391092A3 (en) 1994-01-19
EP0625145A1 (en) 1994-11-23
TW213901B (sr) 1993-10-01
CA2117367A1 (en) 1993-08-05
YU4393A (sr) 1996-01-09
NO942775D0 (no) 1994-07-26
KR950700257A (ko) 1995-01-16
IL104472A0 (en) 1993-05-13
RU94038063A (ru) 1996-05-27
FI943513A7 (fi) 1994-07-26
AU3276193A (en) 1993-09-01
FI943513L (fi) 1994-07-26
HUT70496A (en) 1995-10-30
ZA93582B (en) 1994-07-27
HU9402195D0 (en) 1994-09-28
BR9207071A (pt) 1995-12-05
NO942775L (no) 1994-09-20
MX9300409A (es) 1993-07-01

Similar Documents

Publication Publication Date Title
FI934750A7 (fi) Kommunikationsfoerfarande i TDMA-cellulaermobilradiosystem som anvaender frekvenshoppning
FI935058L (fi) Foer antitumoerbehandling avsedda rekombinant-adenovirus som uttrycker cytokiner
FI930995A7 (fi) Elektronisk spaerrcylinder som inkopplas med stiftkoppling
FI931229L (fi) Som glanspigment laempade blandningar
FI934568A0 (fi) Hydrofobisitet som aostadkommits med metalljonaktivering
FI960156A7 (fi) Bentsyylioksikinuklidiinit aineet P antagonisteina
FI931069L (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
DE69400835D1 (de) Verschmutzungsverhindernde Substanz
FI933560A7 (fi) Radiotelefonsystem som anvaender en flerabonnentenhet
BR9304423A (pt) Ancora
FI934751A0 (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
NO954767D0 (no) 4-amino-17 delser som C17-20-lyase- og 5
FI943513A0 (fi) Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja
FI934764L (fi) Anordning som hindrar krympning av kabelisolering
FI930722A0 (fi) Foerfarande foer framstaellning av polymerer som innehaoller ammoniumgrupper
FI932284L (fi) Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis
DK0640187T4 (da) Ankerfastg relse
ATA151292A (de) Beschlag
FI930219L (fi) Anvaendning av reaktionsblandningar som gjutbara massor
FI935826A0 (fi) Kallsmoerjmedel med delvis neutraliserade fosforsyraestrar som EP-tillsatsaemnen
ATA199692A (de) Schliessstück
ATA151392A (de) Beschlag
FI930721L (fi) Foerfarande foer framstaellning av polymerer som innehaoller aminogrupper
DK0707579T3 (da) Piperidinylsubstituerede methanoanthracener som D1/D2-antagonister og 5 HT2-serotanin-antagonister
FI554U1 (fi) Reklam som aendrar faerg